Key result
Aging and hypertension in rats decreased NO-related vasorelaxant function and vascular GGT activity, but did not lower the vasorelaxant response to GSNO.
In a rat model, aging and hypertension impaired endothelial NO-related dilation and GGT activity but preserved the vasorelaxant response to GSNO, suggesting GSNO as a potential therapeutic for endothelial dysfunction.
Answers are grounded in this paper and cite their sources.
Preserved GSNO vasorelaxation in aged hypertensive rats does not support clinical use; leaves open its evaluation in human endothelial dysfunction.
S‐nitrosoglutathione (GSNO), which is involved in the transport and the storage ofNO, induces vasorelaxation. It requires gamma‐glutamyl transferase (GGT), an enzyme present on the endothelium, to transferNOinto the cell. We evaluated whether aging and hypertension, which induceNO‐related dilating dysfunction, are associated with decreased vascularGGTactivity and modify the vasorelaxant effect ofGSNO. Thoracic aortic rings isolated from male spontaneous hypertensive rats (SHR) and Wistar‐Kyoto rats (WKY) aged 20–22 (adult) or 57–60 weeks (mature) were preconstricted with phenylephrine, then submitted to concentration‐vasorelaxant response curves (maximal response:Emax;pD2) toGSNOand carbachol (the latter to measureNO‐related dilating function).GGTactivity was measured using chromogenic substrate. Both aging and hypertension loweredEmaxvalues for carbachol (Emax−8% in adultSHR, −42% in matureSHRvs. age‐matchedWKY,pageandphypertension < 0.05) demonstratingNO‐related dilating dysfunction. AorticGGTactivity also decreased with aging and hypertension (−22% in adult and −75%, reaching 3 nmol/min/g of tissue, in matureSHRvs. 12 in age‐matchedWKYand 23 in adultWKY,pageandphypertension < 0.05). ThepD2values ofGSNOwere similar in matureSHRandWKYbut higher in adultSHR(pinteraction < 0.05). Aging in hypertensive rats decreasedNO‐related vasorelaxant function and vascularGGTactivity, but did not lower the vasorelaxant response toGSNO. This opens perspectives forGSNO‐based therapeutics restoring nitric oxide bioavailability and vascular protection in a context of endothelial dysfunction.
No takes yet. Share an insight, caveat, or question.
Perrin‐Sarrado et al. (2018) studied Hypertension. Aging and hypertension vs. Normotensive Wistar-Kyoto rats (WKY) was evaluated on Aortic GGT activity (p=< 0.05). Aging and hypertension in rats decreased NO-related vasorelaxant function and vascular GGT activity, but did not lower the vasorelaxant response to GSNO.
Synapse has enriched 10 related papers. Consider them for comparative context: